Annexon Stock Beta
| ANNX Stock | USD 5.14 0.03 0.58% |
Annexon fundamentals help investors to digest information that contributes to Annexon's financial success or failures. It also enables traders to predict the movement of Annexon Stock. The fundamental analysis module provides a way to measure Annexon's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Annexon stock.
Annexon | Beta |
Annexon Company Beta Analysis
Annexon's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Annexon Beta | 1.23 |
Most of Annexon's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Annexon is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Annexon Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Annexon is extremely important. It helps to project a fair market value of Annexon Stock properly, considering its historical fundamentals such as Beta. Since Annexon's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Annexon's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Annexon's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Annexon has a Beta of 1.23. This is 43.02% higher than that of the Biotechnology sector and 11.51% lower than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Annexon Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Annexon's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Annexon could also be used in its relative valuation, which is a method of valuing Annexon by comparing valuation metrics of similar companies.Annexon is currently under evaluation in beta category among its peers.
Annexon Current Valuation Drivers
We derive many important indicators used in calculating different scores of Annexon from analyzing Annexon's financial statements. These drivers represent accounts that assess Annexon's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Annexon's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Enterprise Value | 634.9M | 156.0M | 400.0M | 175.5M | 149.8M | 142.3M |
Annexon ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Annexon's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Annexon's managers, analysts, and investors.Environmental | Governance | Social |
Annexon Institutional Holders
Institutional Holdings refers to the ownership stake in Annexon that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Annexon's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Annexon's value.| Shares | Gmt Capital Corp | 2024-06-30 | 2.9 M | Adage Capital Partners Gp Llc | 2024-06-30 | 2.8 M | Candriam Luxembourg S.c.a. | 2024-06-30 | 2.1 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 2 M | Geode Capital Management, Llc | 2024-06-30 | 1.8 M | State Street Corp | 2024-06-30 | 1.8 M | Marshall Wace Asset Management Ltd | 2024-06-30 | 1.7 M | Jpmorgan Chase & Co | 2024-06-30 | 1.7 M | Nuveen Asset Management, Llc | 2024-06-30 | 1.6 M | Fmr Inc | 2024-09-30 | 8.6 M | Bain Capital Life Sciences Investors, Llc | 2024-06-30 | 8.4 M |
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Annexon will likely underperform.
Annexon Fundamentals
| Return On Equity | -0.42 | ||||
| Return On Asset | -0.25 | ||||
| Current Valuation | 240.58 M | ||||
| Shares Outstanding | 106.59 M | ||||
| Shares Owned By Insiders | 0.49 % | ||||
| Shares Owned By Institutions | 99.51 % | ||||
| Number Of Shares Shorted | 7.77 M | ||||
| Price To Book | 1.66 X | ||||
| EBITDA | (141.57 M) | ||||
| Net Income | (134.24 M) | ||||
| Cash And Equivalents | 177.59 M | ||||
| Cash Per Share | 3.73 X | ||||
| Total Debt | 31.36 M | ||||
| Debt To Equity | 0.20 % | ||||
| Current Ratio | 8.95 X | ||||
| Book Value Per Share | 3.20 X | ||||
| Cash Flow From Operations | (121.14 M) | ||||
| Short Ratio | 6.77 X | ||||
| Earnings Per Share | (1.03) X | ||||
| Price To Earnings To Growth | (0.04) X | ||||
| Target Price | 15.0 | ||||
| Number Of Employees | 71 | ||||
| Beta | 1.23 | ||||
| Market Capitalization | 551.09 M | ||||
| Total Asset | 297.67 M | ||||
| Retained Earnings | (572.5 M) | ||||
| Working Capital | 245.93 M | ||||
| Net Asset | 297.67 M |
About Annexon Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Annexon's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Annexon using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Annexon based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Annexon Stock Analysis
When running Annexon's price analysis, check to measure Annexon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annexon is operating at the current time. Most of Annexon's value examination focuses on studying past and present price action to predict the probability of Annexon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annexon's price. Additionally, you may evaluate how the addition of Annexon to your portfolios can decrease your overall portfolio volatility.